South Brisbane, Australia: The long-term inhalation of cannabis smoke does not impact lung function in the same manner as inhaling tobacco, according to longitudinal data published in the journal Respiratory Medicine. A team of Australian researchers evaluated the impact of tobacco smoking and cannabis smoking on lung function in a cohort of 30-year-old subjects. Study participants began smoking cannabis, tobacco, or both as young …
Ithaca, NY: The adoption of statewide marijuana legalization laws is associated with reductions in the amount of codeine dispensed at retail pharmacies, according to data published in the journal Health Economics. A team of researchers affiliated with Cornell University in New York and with George Mason University in Virginia assessed the impact of adult-use cannabis legalization laws on shipments of opioids to hospitals, pharmacies, …
Washington, DC: State-level marijuana legalization laws are not associated with a statistically significant increase in rates of psychosis-related health outcomes, according to data published in the Journal of the American Medical Association (JAMA) Network Open. A team of Stanford University investigators evaluated the relationship between the adoption of statewide legalization laws and rates of psychosis-related health care claims among a cohort of over 63 …
London, United Kingdom: The daily administration of cannabis products is associated with reductions in seizure frequency among children with treatment-resistant epilepsy (TRE), according to observational trial data published in the journal Neuropediatrics. British investigators assessed the safety and efficacy of cannabis-derived products in 35 patients diagnosed with pediatric epilepsy. Study subjects were participants in the UK Medical Cannabis Registry, and each of them possessed a …
London, United Kingdom: The use of cannabis products containing THC and CBD are safe and effective in mitigating symptoms in patients diagnosed with emotionally unstable personality disorder (EUPD), according to a case series reported in the journal Brain Sciences. Emotionally unstable personality disorder (a/k/a borderline personality disorder) is a common mental health disorder associated with a range of chronic and debilitating symptoms, including impaired social …
Chicago, IL: Neither current nor past cannabis use is associated with an elevated risk of high blood pressure, according to data published in the Journal of Clinical Hypertension. Investigators with Northwestern University’s Feinberg School of Medicine in Chicago assessed the relationship between cannabis use and blood pressure in a cohort of 4,565 adults. They found no correlation between cannabis consumption and the likelihood of …
Barcelona, Spain: Adults who regularly consume cannabis products do not report significant differences in their overall health as compared to the general public, according to data published in the journal Cannabis and Cannabinoid Research. Spanish investigators surveyed a representative sample of regular cannabis consumers on a variety of questions specific to their daily activities and perceived overall health. Their responses were compared to previously …
MELBOURNE, Australia, Jan. 14, 2023 (GLOBE NEWSWIRE) — The cannabis plant, cannabis sativa, contains 80-100 cannabinoids, including delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). When cannabinoids act on the body’s endocannabinoid system (the communication system naturally found in the body and brain), they can regulate activities such as mood, memory, sleep and appetite. Experts at Levin Health, an Australian sports science company …
Minneapolis, MN: Residents of states where cannabis is legal do not possess elevated rates of psychosis, and they are also less likely to exhibit symptoms of alcohol abuse, according to longitudinal data published in the journal Psychological Medicine. A team of researchers affiliated with the University of Minnesota and the University of Colorado assessed the relationship between adult-use cannabis legalization and psychosocial functioning in …
London, United Kingdom: The daily administration of cannabis products is associated with symptom improvements in patients with inflammatory bowel disease, according to observational trial data published in the journal Expert Review of Gastroenterology & Hepatology. British investigators assessed the safety and efficacy of cannabis products in 76 patients diagnosed with either Crohn’s disease or ulcerative colitis. The study subjects were participants in the UK Medical Cannabis …